Cardiff Oncology Reports Full Year 2025 Results and Provides Business Update
February 24, 2026 16:30 ET | Source: Cardiff Oncology, Inc. Reported positive…
Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results
February 20, 2026 17:16 ET | Source: Constellation Software Inc. TORONTO, Feb.…
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position…
GigaCloud Technology Inc to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 26, 2026
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif.,…
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscias Platform
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital…
Inventiva reports preliminary 2025 fiscal year financial results
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term…
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
February 13, 2026 16:30 ET | Source: Natural Alternatives International Inc CARLSBAD,…
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026
US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million…
Ocean Tomo Releases 2025 Intangible Asset Market Value Study Results
50-year study of the US market and 20 years of foreign market…
Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
